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In order to improve and continuously develop the quality of pharmaceutical products,
the process analytical technology (PAT) framework has been adopted by the US
Food and Drug Administration. One of the aims of PAT is to identify critical process
parameters and their effect on the quality of the final product. Real time analysis of
the process data enables better control of the processes to obtain a high quality
product.
The main purpose of this work was to monitor crucial pharmaceutical unit
operations (from blending to coating) and to examine the effect of processing on
solid-state transformations and physical properties. The tools used were near-
infrared (NIR) and Raman spectroscopy combined with multivariate data analysis, as
well as X-ray powder diffraction (XRPD) and terahertz pulsed imaging (TPI).
To detect process-induced transformations in active pharmaceutical ingredients
(APIs), samples were taken after blending, granulation, extrusion, spheronisation,
and drying. These samples were monitored by XRPD, Raman, and NIR spectroscopy
showing hydrate formation in the case of theophylline and nitrofurantoin. For
erythromycin dihydrate formation of the isomorphic dehydrate was critical. Thus, the
main focus was on the drying process. NIR spectroscopy was applied in-line during a
fluid-bed drying process. Multivariate data analysis (principal component analysis)
enabled detection of the dehydrate formation at temperatures above 45°C.
Furthermore, a small-scale rotating plate device was tested to provide an insight
into film coating. The process was monitored using NIR spectroscopy. A calibration
model, using partial least squares regression, was set up and applied to data
obtained by in-line NIR measurements of a coating drum process. The predicted
coating thickness agreed with the measured coating thickness. For investigating the
quality of film coatings TPI was used to create a 3-D image of a coated tablet. With
this technique it was possible to determine coating layer thickness, distribution,
reproducibility, and uniformity. In addition, it was possible to localise defects of either
the coating or the tablet.
It can be concluded from this work that the applied techniques increased the
understanding of physico-chemical properties of drugs and drug products during and
after processing. They additionally provided useful information to improve and verify
the quality of pharmaceutical dosage forms.
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1. Introduction
Approaches to investigate the manufacturing and processing of pharmaceutical
formulations have gained more attention within recent years. The aims are to both,
find new ways of processing active pharmaceutical ingredients (APIs) and excipients,
and to better understand the underlying principles of currently used processes and
induced transformations.
During manufacturing the materials being processed are subjected to mechanical
and/or thermal stresses and are often exposed to solvents, such as water. These
stresses may induce process-induced transformations (PITs) and thus affect the
quality and properties of the final product. In order to determine critical steps during
manufacturing in which these PITs take place, the physico-chemical properties of
APIs and excipients should be taken into consideration, as well as the knowledge
about the kinds of stresses applied during the different steps. This knowledge should
give clues as to which processes should be monitored closely for potential PITs.
Nevertheless, most PITs are difficult to predict and model (Morris et al. 2001). Thus,
it has proven useful to first take samples after every processing step and examine
these samples with easily applicable at-line techniques. In addition to monitoring
solid-state changes, other physical properties, for example, particle size, particle size
distribution, and change of sample texture (Norris & Williams 1983) should be closely
examined during processing. Measuring theses properties throughout the process,
rather than relying solely on end-product testing, will better ensure the quality of the
product.
To identify and monitor these critical steps process analytical technology (PAT) is
used, which is defined by the US Food and Drug Administration (FDA) as follows:
“PAT is a system for designing, analyzing, and controlling manufacturing through
timely measurements […] with the final goal of ensuring final product quality (FDA
2004a)”. PAT analysis can be done either in-line (sample not removed or diverted
from the process), on-line (sample diverted and returned to the process), at-line
(sample removed and analysed in the process area) or off-line (sample removed
from process area). The concept combines four main areas: monitoring, supervision,
control and diagnosis (Rodrigues et al. 2006). It has come into focus in the
pharmaceutical industry as a promising concept to increase product quality while
lowering the manufacturing costs and reducing the time to market for newly
developed pharmaceutical products.
Spectroscopic techniques, such as mid-infrared, near-infrared (NIR), and Raman
spectroscopy, are widely used for real-time measurements and quality control. NIR
spectroscopy has become a synonym for PAT being already implemented for
decades within the agricultural, food and chemical industries. The European Agency
for Evaluation of Medical Products (EMEA) has published a detailed guideline on the
use of NIR spectroscopy (EMEA 2003). Nevertheless, there are more techniques
available for investigating manufacturing processes. In addition to mid-infrared and
Raman spectroscopy, terahertz pulsed spectroscopy (TPS) and terahertz pulsed
imaging (TPI) are relatively new techniques. Both have shown great potential in the
INTRODUCTION
2
field of polymorph identification (Strachan et al. 2005) and film coating quality
determination (Fitzgerald et al. 2005). In-line measurements are not possible with all
techniques they often require labour intensive, time consuming calibration and data
processing. But, if applied wisely, such techniques can provide an in depth
understanding of a process. X-ray powder diffraction (XRPD) is often used off-line or
at-line for identifying solid-state changes of crystalline material, as is differential
scanning calorimetry (DSC) for detecting endothermic or exothermic events. Benefits
that one can expect from the application of PAT during the different unit operations
are presented in Table 1.
Table 1. Possibilities for monitoring and investigating pharmaceutical unit operations
(modified from Bakeev 2003, Rantanen 2007, Räsänen & Sandler 2007).
Critical quality parameter
Pharmaceutical
unit operations
Information obtained by process
analytical tools
Qualification, particle size distribution Raw materials, chemical and physicalproperties
Yield, purity, degradation By-products and rate constants, end-point
Polymorphic forms, speed of crystallisation,
purity, surface properties, particle size and
shape distribution
Crystallisation progress, important
process operating conditions, degree of
crystallinity, solid-state transformation ?
particle design at molecular level
Particle size reduction, phase transitions
Polymorphic transformations, creation of
amorphous material, particle size
development
Homogeneity Real time blend uniformity, end-point
Particle size distribution, phase transitions
(solvent exposure, thermal and
mechanical stress)
Particle size, moisture content, phase
transitions, end-point
Phase transitions (desolvation,
dehydration)
Dehydration/desolvation process
(moisture loss), end-point
Relative density, tensile strength, Young’s
modulus, phase transitions
Physical properties, polymorphic
transformations, pressure-induced
amorphisation, content uniformity
Coating thickness and uniformity,
interaction of coating solution and tablet
core material
Coating time and coating thickness,
coating variations and uniformity
Degradation products, identification of
counterfeits Identification, stability
In this thesis hydrate formation and dehydration behaviour were investigated during
blending, pelletisation, and drying. Raman, NIR spectroscopy, and XRPD have been
applied to assess the changes in solid-state properties. In-line NIR spectroscopy was
used to monitor the dehydration behaviour of pellets containing erythromycin (EM)
during fluid-bed drying. The coating process of compacts was investigated and a
calibration model using in-line NIR data of a small-scale coating method was applied
to determine the coating thickness of tablets during a coating drum process.
Furthermore, coating quality parameters of sustained-release coated tablets, such as
coating thickness, distribution, and uniformity were determined using TPI.
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2. Theory and literature review
2.1. Process analytical technology
With the aim of making pharmaceutical production more efficient and manufacturing
higher quality products in which the quality is built in (FDA 2004a), the FDA released
a new version of the pharmaceutical current Good Manufacturing Practices (cGMPs)
in 2004 (FDA 2004b). To encourage implementation of risk-based approaches they
additionally released the PAT guideline as non-binding recommendations. The idea
behind this emerged because for various drugs neither the mechanisms of
degradation, drug release and absorption nor the effects of production were fully
understood. The final aim of PAT is to replace conventional quality assurance and
quality control methods with techniques that enable real-time release (FDA 2004a).
PAT is certainly not a new concept and has been known as process analytical
chemistry (Beebe et al. 1993, Baughman 2005, Workman et al. 2007). Other
industries (Workman 1999), including the paper industry (Workman 2001) and food
science (Tenhunen et al. 1994, Huang et al. 2008), have used this concept for
decades but regulatory burden has delayed such progress in the pharmaceutical
industry.
Long before this guideline was published research was conducted to show the
benefits of PAT. A review about PAT applications in the pharmaceutical industry,
including raw material qualification, moisture content analysis, dehydration of hydrate
and solvates during processes was published by Morris et al. (1998). In another
study the focus was on complications for solid formulations that arise from their
chemical reactivity (Byrn et al. 2001). In this study solid-state changes, as well as
oxidation of APIs and incompatibility reactions between drugs and excipients were
investigated. The need for monitoring processes and identifying possible solid-state
reactions was clearly shown. Investigating the process of crystallisation is also a
focus of PAT due to its potential in the detection of polymorphic forms (Févotte et al.
2004). The influence of thermodynamics on the different polymorphic forms can be
assessed by monitoring the crystallisation process with different in-line and at-line
techniques. Particle size and shape evolution during crystallisation can also be
investigated by NIR spectroscopy and image analysis (Yu et al. 2004). The combined
information may assist to adjust and improve the control of a crystallisation process.
Zhang et al. (2004) published their results on PITs concluding that the underlying
mechanism of the phase transition and critical process parameters are crucial
information in designing a rational formulation. Similar conclusions were obtained
when examining the processes of melt granulation and tablet coating by NIR
spectroscopy and NIR imaging (Roggo et al. 2005). An example of PAT
implementation is presented in a study ranging from the feasibility testing of NIR
spectroscopy in quantifying the drug content of tablets, to determining tablet
hardness and calibration transfer between different kinds of NIR spectrometers
(Cogdill et al. 2005 a, b, c).
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All this research demonstrates that the necessary information about APIs,
excipients, and processes for modelling possible polymorphic forms, PITs,
incompatibilities, dissolution profiles, and bioavailability can be obtained using PAT.
Not only is knowledge about the optimal physico-chemical and pharmaceutical
properties of an API required, but also knowledge of the processes applied and the
critical steps associated with physical and chemical changes, so that such changes
can be controlled (ICH 1999, ICH 2005, ICH 2007).
2.2. Solid-state transformations during processing
Solid forms can exhibit polymorphism, which can be categorised into true
polymorphs, solvates/hydrates (pseudo-polymorphs), isomorphic desolvates/
dehydrates, and amorphous solids. True polymorphs are of the same chemical
composition but exhibit different crystalline modifications. Solvates and hydrates are
also crystalline but include solvent molecules (water in the case of hydrates) in their
crystal lattice. Isomorphic desolvates/dehydrates exhibit only minor structural
differences from the solvate/hydrate apart from the lack of solvent molecules.
Amorphous material lacks the long-range structural order that crystalline materials
possess (Yu et al. 1998).
The different solid states of a substance exhibit different physico-chemical and
pharmaceutical properties. This may have an effect on powder flow, tablet hardness,
and compressibility during processing. Even after production storage stability,
dissolution rate, and bioavailability may differ between the different solid-state forms
due to different melting points, densities, dissolution rates, and solubilities (Halebian
& McCrone 1969, Grant 1999, Yu et al. 1998). Screening for the polymorphic
structure of APIs is required from the regulatory bodies for newly developed drugs,
e.g. the International Conference for Harmonisation (ICH 1999). In addition, it offers
the possibility to patent polymorphic forms, to study structure-property relationships,
and finally to engineer solids with optimised properties (Yu et al. 1998, Zhang et al.
2004).
The formation of true polymorphic structures depends on thermodynamic and
kinetic factors. The most common classification for true polymorphs divides them into
enantiotropic and monotropic systems (Giron 1995, Halebian & McCrone 1969). In
an enantiotropic system different polymorphic forms may coexist in a certain
temperature range or convert to a metastable intermediate during transition. The
thermodynamically stable form is the form with the lower free energy. Even though
the thermodynamically stable form at ambient conditions usually shows preferable
process and storage stability, it is not necessarily the preferred form, since the
apparent solubility is lower. Forms with the higher thermodynamic activity, on the
other hand, possess a more favourable apparent solubility and dissolution rate. In a
monotropic system the different polymorphs usually do not coexist. The system
converts only in one direction: from the thermodynamically less stable form to the
more stable form that has the higher melting point. A metastable form can only occur
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through kinetic conversion. Any stress applied to this kind of polymorphic system can
yield the stable form (Morris et al. 2001).
To better understand the underlying behaviour of a solid-state system,
thermodynamic measurements provide information about the number of phases, the
states of aggregation, the stability of the detected phase in relation to temperature
and pressure, and the latent heat of transitions (Morris et al. 2001).
Methods to determine thermodynamic properties include differential scanning
calorimetry (DSC), thermogravimetric analysis, microcalorimetry, and solution
calorimetry (Ph.Eur. 2008a). By measuring the heat flow versus temperature, DSC
can detect melting point, heat capacity, heat of fusion/transition, solid-solid phase
transitions, as well as the lattice relaxation (Vyazovkin & Dranca 2005). DSC is
further able to assess the glass transition temperature (Tg), which characterises
amorphous solids. For polymorphic mixes DSC can detect melting point depression
and eutectic melting (Hoppu et al. 2007). Solution calorimetry, which measures the
heat of solvation, is a sensitive method to detect amorphous solids and quantify the
crystalline-amorphous mixtures (Lehto et al. 2006). Amorphous materials usually
show an increase in heat of crystallisation and solvation.
Polymorphic forms can also be characterised by microscopy (Mirza et al. 2003),
hot stage microscopy (Mirza et al. 2006) or scanning electron microscopy (Aaltonen
et al. 2006). Differences can be seen in morphology, refractive indices, and
birefringence. Desolvates are characterised by microcrystalline domains and
amorphous solids are readily detectable by their lack of birefringence. Often moisture
sorption/desorption isotherms can be used to predict storage stability. Thus, the
kinetics of dehydration and crystallisation can be assessed by measuring the change
of mass versus relative humidity.
Methods to characterise the different solid-state forms on a molecular and particle
level are described in Table 2. Stephenson (2005) has published a detailed paper
about XRPD, presenting it as a suitable tool for high throughput screening, routinely
used for polymorphic screening. In two studies the limit of quantitation of thermal and
diffraction methods and vibrational spectroscopy was compared (Giron et al. 2007,
Lehto et al. 2006). One of the most frequently used APIs to study polymorphism is
carbamazepine. Polymorphic forms have been verified with TPS (Strachan et al.
2005), solid-state nuclear magnetic resonance (NMR) spectroscopy and XRPD
(Harris et al. 2005).
A significant effort has been put into stabilising amorphous forms of drugs with low
solubility of their crystalline form. Amorphous materials have the advantage of a high
apparent solubility, but tend to crystallise during processing or storage. One
successful attempt to stabilise amorphous material was to decrease the molecular
mobility by annealing (Luthra et al. 2008). Another route to increase the solubility is to
stabilise the anhydrous form as a solid dispersion, for example, erythromycin
dihydrate in polyethylene glycol 6000 (Mirza et al. 2006). Since water is the most
common solvent during pharmaceutical processes, hydrates and dehydrated forms
will be discussed in more detail.
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Table 2. Use of diffraction and vibrational spectroscopy to detect solid-state changes
(modified from Giron et al. 2004, Yu et al. 1998).
Types of polymorphs and
information
Data measured Features
Single crystal
XRD
True polymorphs & solvates:
unit cell parameters, molecular
conformation and packing
Difficulties to prepare single crystal (phase
purity)
XRPD
(Ph.Eur. 2008b)
True polymorphs & solvates:
diffraction peaks, phase purity,
% crystallinity
Isomorphic desolvates: only
subtle changes
Amorphous solids: no
diffraction peaks
Polymorphic mixes:
quantification
Diffractogram:
diffraction intensity as
a function either of
the scattering angle
or scattering vector.
Sensitive to long-
range order
Influenced by preferred orientation,
variable temperature XRPD,
combination with humidity control: studying
polymorphic conversions
TPS True polymorphs, solvates &
isomorphic desolvates:
hydrogen bonding, low energy
lattice vibrations, % crystallinity
Amorphous solids: diffuse
response
Polymorphic mixes:
quantification
Spectra: dipole
moment change,
intermolecular
vibration and
molecular flexing
Mode: transmission, specular reflectance,
attenuated total reflection (ATR);
rapid, sensitive to water vapour, detected
modes not yet fully assigned
Solid-state
NMR
True polymorphs:
chemical shifts: phase purity,
molecular mobility
Solvates: solvent resonance
peaks, solvent mobility, shifted
drug resonances
Isomorphic desolvates:
disappearing solvent
resonances, drug resonance
shift
Amorphous solids: peak
broadening
Polymorphic mixes:
quantification
Spectra: magnetic
resonance, sensitivity
to electronic
environment of
specific nuclei
Variable temperature solid-state-NMR:
molecular dynamics
FT-IR
Spectroscopy
(Ph.Eur. 2008c)
True polymorphs: band shifts
Solvates: identification of
solvent
Amorphous solids: peak
broadening
Polymorphic mixes:
quantification
Spectra: dipole
moment change,
hydrogen bonding
Mode: transmission, diffuse reflectance
infrared Fourier-transform (DRIFT), ATR;
combination with heat cell, microscopy,
sample preparation in transmission and ATR
can induce polymorphic transformations
Burger´s infrared rule (attempt to predict
stability): for polymorphs dominated by
hydrogen bonding the polymorph with the
first absorption band at higher frequency will
have higher entropy, thus be less stable.
NIR
Spectroscopy
(Ph.Eur. 2008d)
True polymorphs & solvates:
band shift and splitting –
change of molecular symmetry
Isomorphic desolvates: loss
of solvent peaks, shift of drug
peaks, hydrogen bonding
interaction
Amorphous solids: peak
broadening, lack of low
frequency vibrations,
molecular mobility
Spectra: overtone
and combinations of
FT-IR spectral bands,
dipole moment
change, scattering
differences
Mode: transmission, diffuse reflectance,
transflectance;
sensitivity to water;
multivariate data analysis: separation of
physical from chemical information.
Raman
Spectroscopy
(Ph.Eur. 2008e)
Isomorphic desolvates: loss
of solvent peaks, shift of drug
peaks
Amorphous solids: peak
broadening
Spectra: change in
polarisability, Stokes
scatter presented as
Raman shift cm-1
Mode: backscatter, transmission,
combination with microscopy;
complementary information to IR, no sample
preparation, not water sensitive,
fluorescence (also of excipients) interferes,
local sample heating (Johansson et al. 2002)
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2.2.1. Hydrate formation
The formation of hydrates, a subclass of solvates, has been reported for a significant
number of the APIs (Bechtloff et al. 2001). Hydrates usually exhibit different crystal
packing, thus showing changes in intermolecular interactions and crystalline order.
These changes influence solubility, dissolution rate, stability, and bioavailability
(Khankari & Grant 1995). The nearly ubiquitous presence of water in various
pharmaceutical manufacturing steps underlines the importance of monitoring hydrate
formation during critical processing steps (e.g. wet granulation, aqueous film-
coating).
Hydrates can be classified into isolated site hydrates, channel hydrates, and ion
associated hydrates (Morris 1999) depending on the location of the water molecules
in the crystal structure of the API. In isolated site hydrates water molecules are
located in a manner such that they are not in direct contact. Channel hydrates
provide channels or planes to accommodate the water molecules, which are usually
located next to each other. Channel hydrates release the water molecules more
readily than isolated site hydrates and can result in isomorphic, dehydrated
structures. In this situation the crystal structure of the channel hydrate merely relaxes
upon dehydration, creating a hygroscopic anhydrous form (Stephenson et al. 1998).
The process is reversible; in high humidity the crystal lattice expands to take up
water molecules (Datta & Grant 2004). In the last category, the ion associated
hydrates, water molecules are coordinated by ions that are incorporated in the crystal
lattice.
The effects of relative humidity and water activity are important when determining
whether the hydrate or the anhydrous form of an API is stable under the applied
conditions (Li et al. 2008). Since the anhydrate has a higher free energy, the
bioavailability is usually higher than for the corresponding hydrate. Therefore,
anhydrous forms are often favoured for manufacturing. A study revealed that the
thermodynamically more stable anhydrate of carbamazepine (form III) had a lower
intrinsic solubility than the thermodynamically less stable anhydrate (form I) but a
higher bioavailability. The thermodynamically less stable anhydrate and the dihydrate
showed comparable results concerning the bioavailability, which is a result of the fast
transformation of form I into the dihydrate form in solution (Kobayashi et al. 2000).
Transformations of azithromycin anhydrate, dihydrate, and monohydrate were
studied in accelerated storage conditions using NIR spectroscopy to assess the
stability (Blanco et al. 2005). NIR spectroscopy was used to identify the most stable
form as the dihydrate, which supported the findings of Gandhi et al. (2002). NIR and
Raman spectroscopy were used to monitor theophylline and caffeine hydrate
formation during wet granulation (Jørgensen et al. 2002).
2.2.2. Dehydration
The mechanism of dehydration of organic solids has been studied extensively. The
topic is highly relevant for pharmaceutical research because in nearly every
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production cycle of pharmaceutics the intermediate or final product will be exposed to
a drying step of some sort. The formation of different polymorphs (Petit et al. 2007),
amorphous material, or hygroscopic dehydrated forms (Stephenson et al. 1998) may
result in further solid-state transformations during storage, which in their turn may
result in different stability and bioavailability.
With the aim to model dehydration behaviour Petit and Coquerel (1996) have
proposed a dehydration theory based on their investigation of dehydrate and
anhydrous copper (II) 8-hydroxyquinolinate. Depending on certain criteria the
removal of water can be classified as destructive or cooperative (Figure 1). In
essence, this can be explained as follows: if sufficiently large planes or channels
exist in the molecular structure of a hydrate (I), water will be released cooperatively
accompanied by a decrease of molecular volume of the crystal and an overall
decrease in the identical structural order (I*). If the water release does not induce
significant deformation in the crystal, the resulting form will be isomorphic (I’) to the
hydrate structure and will have a high probability of converting back into the hydrate
form at higher relative humidity. This process belongs to the class II topotactic
mechanism. If the release of water does not appear smoothly, but results in domains
with cracks and defects, the crystal will reorganise (class II cooperative-
reorganisation) but retain structures of the hydrate form (Ia). If these domains are
small and sufficiently numerous, the surface energy will be too high for reorganisation
and either the system will crystallise via a nucleation growth process (class I
cooperative-crystallisation) and form a new crystal structure (II) or result in
amorphous material (class I cooperative-disorganisation). If the planes or channels,
however, are not large enough or the liberation energy of the water molecules is too
high, the process will result in destruction of the crystal phase.
Figure 1. Possible dehydration mechanisms for a hydrate (adopted from Petit & Coquerel
1996).
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In  the  class  I destructive-disorganisation mechanism no nucleation growth process
occurs and the final material will be amorphous. The other possibility is the class I
destructive-crystallisation mechanism. In this case nucleation occurs and a new
crystal (II) is formed. All prior structural information is consequently lost.
It should be noted that the kinetics of the dehydration process may lead to
different mechanisms. Garnier et al. (2002) differentiate between smooth and hard
dehydration conditions. For example, if water evaporates slowly, a certain material
may follow the class II cooperative-reorganisation mechanism. Higher temperature
and lower relative humidity can cause a class I cooperative mechanism for the same
material. Nevertheless, heat and relative humidity are not the only parameters that
significantly influence the dehydration kinetics. In order to investigate the dehydration
process, one should also consider thermodynamic parameters, structural features of
the hydrate, and physical factors (size, shape, defects) (Petit et al. 2007). Mechanical
stress can also generate surface defects or induce local heating of the crystal due to,
for example, milling and pressure during tabletting (Zhang et al. 2004).
Another classification scheme has been introduced by Galwey (2000) using the
manner in which water evaporates as a criterion for the classification and the
structural changes that occur after the loss of water to subdivide each class.
2.3. Vibrational spectroscopy
Since the PAT initiative of the FDA at the beginning of this decade, vibrational
spectroscopy has steadily gained importance in pharmaceutical research and
industry. This initiative resulted in the general conclusion that “quality cannot be
tested into products; it should be built in or should be by design” (FDA 2004a).
Vibrational spectroscopy offers a lot of advantages for PAT applications ranging from
fast data acquisition with non-destructive and non-invasive measurements to minimal
or no need for sample preparation. The techniques provide different information
about the molecular state and its changes. Raman spectroscopy probes the change
in polarisability while infrared spectroscopy measures a change of dipole moment in
a molecule. Available methods should therefore be used in complement with each
other in order to obtain a more complete picture of the molecular structure of the
compound (Giron et al. 2002). A combination of the spectroscopic methods has been
particularly beneficial for polymorph screening (Aaltonen et al. 2007a). In addition,
other methods like XRPD and microscopic methods should be also taken into
consideration for investigating polymorphism (Yu et al. 1998).
Absorption of electromagnetic radiation occurs when the energy of the radiation
correlates with the energy of molecular vibration within a molecule. The forms of
energy that contribute to the absorption in the infrared region are vibrational energy
(component atoms vibrate around the mean centre of their chemical bond) and
rotational energy (tumbling motion). The infrared region can be divided into near-
(12800 – 4000 cm-1), mid- (4000 – 400 cm-1), and far-infrared (400 – 10 cm-1)
regions. The far-infrared region includes the region that is known as the terahertz
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gap. Rotational energy of the molecules mainly accounts for absorption in the far-
infrared region. Molecular vibrations can be classified into stretching, if the distance
between the atoms changes and bending, if the bond angle changes. In general
bending vibrations occur at lower frequencies than the corresponding stretching
vibrations (Coates 2000). Also the bond strength and the mass of the atoms can be
correlated to the frequencies at which the molecule absorbs: the stronger the bond
(single, double, triple bond) the higher the frequency and the greater the mass of the
atoms the lower the frequency.
In the mid-infrared region largely fundamental vibrations occur, which correspond
to the excitation from the ground electronic state (?0) to the first excited vibrational
energy state (? 1). NIR region corresponds to overtones (?2, ?3, …) and combinations
of the fundamental vibrations, mainly of CH and OH stretch combination bands and
CH, OH and NH overtones (Figure 2a).
A molecule is infrared active if the dipole changes upon vibration. The larger the
dipole change the stronger the intensity of the absorption band. For being Raman
active a molecule requires a change in polarisability (inducing a dipole) during the
vibration or rotation. This dipole emits or scatters light at the optical frequency of the
incident light wave. Often infrared active molecules with a dipole are not Raman
active and vice versa. The two techniques should be considered as complimentary,
as can be seen in Figure 2b showing fundamental stretching (?) and deformation (?)
vibrations occurring in Raman and infrared spectroscopy.
Figure 2. Characteristic overtone and combination vibrations in the near-infrared region
(a). Absorbance bands and lattice vibrations (LV) in Raman (green: strong signal, blue:
medium signal) and infrared (red: strong signal, orange: medium signal) spectroscopy (b), X
= N, O, C and S (modified from Coates 2000, McCreery 2000, Workman 2000).
For quantitative analysis in Raman spectroscopy the intensity of the signal is
directly related to the concentration of the compound (Siesler 2002). In the case of
ultraviolet/visible, mid-infrared, near-infrared, and far-infrared spectroscopy the Beer
Lambert law (Eq. 1) can be used as a reasonable approximation for the
concentration of a component in a system. It describes the linear relationship
THEORY AND LITERATURE REVIEW
11
between the absorbance (A) and the molar concentration (c) using the molar
absorptivity (?) and the optical pathlength (d).
(1)
Due to the complexity of most systems measured the Beer Lambert law has to be
modified to account for interference by other components in the system and for
different morphologies, which result in different interaction of the radiation with the
sample. Nevertheless, using the Beer Lambert law one can develop calibrations
relating spectral signal to sample concentration (Heise & Winzen 2002).
2.3.1. Near-infrared spectroscopy
The probability of transitions to higher excited states (>? 1) is considerably lower
compared to transitions to the first excited vibrational energy state (? 1), which leads
to one of the major advantages of NIR spectroscopy: while the sample has to be
diluted for analysis using mid-infrared spectroscopy due to the high level of
absorption, NIR spectroscopy can recorded spectra without any sample preparation.
The molar absorptivity in the NIR region is usually 10 – 100 times weaker compared
to the absorptivity of the corresponding fundamental bands in the mid-infrared region
(Reich 2005). The lower molar absorptivity and the lower frequencies used in the NIR
region result in another advantage: NIR radiation has a greater penetration depth
compared to mid-infrared radiation.
One of the disadvantages of NIR spectroscopy is the broad overlapping bands in
the spectra, which makes interpretation more difficult (Reich 2005). This leads to
restricted sensitivity and poor resolution. The interfering physical information,
resulting in baseline effects and the need to extract chemical information from these
complex spectra, calls for multivariate data analysis (Heise & Winzen 2002).
For in-line applications NIR measurements are performed in combination with a
diffuse reflectance probe attached by fibre optics to the spectrometer. An incident
beam hits the surface of the sample with one part of the beam being reflected, with a
specular and a diffuse component, and the other part being transmitted. The diffusely
reflected light accounts for most of the spectral information obtained by NIR
reflectance spectroscopy and can be divided into refracted, randomly reflected, and
scattered components. The reflected light contains chemical information leading to
the identification of materials or quantification of the absorbent concentration (Blanco
et al. 1999) using the Beer Lambert law (Eq. 1). In a similar manner the coating
thickness can be determined (Kirsch & Drennen 1995, 1996).
Physical properties of the sample affect the reflected light and interfere with the
chemical information of the spectra. This can also be used to determine particle size
changes (Ciurczak et al. 1986, O’Neil et al. 1999, Otsuka 2004, Rantanen & Yliruusi
1998, Rantanen et al. 2005) during a process. The decrease in scattering due to an
increase of particle size leads to deeper penetration of the light and thus to an
increase of apparent absorbance. Another parameter that can be assessed is the
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density of the sample, which has been used to predict the crushing strength of tablets
(Kirsch & Drennen 1995), the density of compacts produced by roller compaction
(Gupta et al. 2005), and the rheological properties of a granulated mass (Jørgensen
et al. 2004).
Despite the dependence on multivariate data analysis for extracting information
from NIR spectral data, numerous applications for NIR spectroscopy have been
found in pharmaceutical research and industry: the identification of raw materials for
example different grades of pharmaceutical excipients (Yoon et al. 1998) or
counterfeit drugs (Scafi & Pasquini 2001), monitoring the blend uniformity on-line
(Hailey et al. 1996), and measurement of coating thickness (Andersson et al. 1999,
2000, Pérez-Ramos et al. 2005). In addition, critical parameters during drying for low-
melting APIs (Wildfong et al. 2002) and the drug content in mucoadhesive thin-film
composites have been investigated (Fountain et al. 2003).
Moisture content analysis is another broad application in many industries
including pharmaceuticals (Berntsson et al. 1997, Rantanen et al. 1998, 2000), since
water is a strong absorber in the NIR region. NIR spectroscopy is very sensitive to
the presence of water molecules (Stein & Amrose 1963) and hydrogen bonds
(Maeda et al. 1995). The combination band of water is located at 1940 nm and the
first overtone vibration can be found at 1450 nm. Depending on the interactions of
water with solids these bands can shift, enabling the distinction between hydrate
bound water and liquid water (Buckton et al. 1998, Jørgensen et al. 2002).
Furthermore, NIR spectroscopy was able to detect polymorphic forms (Yu et al.
1998) and hydrate formation (Crucio and Petty 1951, Jørgensen et al. 2002,
Kogermann et al. 2007, Aaltonen et al. 2007b).
Calibration models for NIR measurements, for example, to quantify the content of
API in a tablet can be time consuming to prepare. Blanco et al. (2000, 2008) have
therefore investigated the possibility of reducing the time and work load for these
calibration models. They produced laboratory samples with sufficient variability
(Blanco et al. 2008) to prepare a single PLS regression model that assessed the API
content in the blend and the final tablets. This model was then used to predict the
API content of production samples. The extent of polymorphic transformation during
granulation was modelled separately using multivariate curve resolution – alternating
least squares; a method that can provide spectral and concentration profiles for an
evolving process (de Juan & Tauler 2003, 2006). Recently, Abrahamsson et al.
(2005) measured the API content of intact tablets using time-resolved transmission
NIR spectroscopy, which is less sensitive towards the physical properties of tablets.
For further information about NIR spectroscopy in the pharmaceutical field the
reader is referred to the review articles, which have been published by Luypaert et al.
(2007), Räsänen & Sandler (2006), and Reich (2005). Interesting reviews from other
scientific fields have been published by Huang et al. 2008, who has discussed use of
NIR spectroscopy in the food and beverage industry, and Workman (1999), who has
published an extensive review about NIR and infrared spectroscopy. He gives
examples for applications and different measurement methods in a variety of fields.
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2.3.2. Terahertz pulsed spectroscopy and imaging
Terahertz spectroscopy has been under development for years before more efficient
power sources (ultra-short pulsed lasers) and more sensitive detectors
(semiconductor receivers) made it available for broader use. Applications for
terahertz spectroscopy have been tested, for example, in the medical field of cancer
detection (Woodward et al. 2003), and imaging of teeth (Crawley et al. 2003), as well
as for material characterisation. Ferguson and Zhang (2002) have published a
detailed review on different terahertz spectroscopic systems and their current
applications. The discussion includes advantages and disadvantages of the available
terahertz sources (using either photoconduction or optical rectification) and terahertz
detectors. In the past highly sensitive terahertz detectors (e.g. helium cooled silicon
bolometer) were required that were cryogenically cooled to reduce the interference of
the thermal background. The commercially available set-up (TPS 2000TM, TeraView
Ltd, Cambridge, UK) uses NIR laser pulses at 80 MHz, which are focussed onto a
GaAs photoconductive switch acting as the terahertz emitter. The laser beam
generates electron-hole pairs, which are accelerated in an electric field and
consequently emit pulsed terahertz radiation. An optically gated semiconductor
receiver antenna (similar to the terahertz emitter) is used for detection of the
terahertz signal that passes through the sample. A small part of the incident NIR
laser pulse is directed via an optical delay-line onto the semiconductor receiver,
generating electron-hole pairs. The resulting electric field induces a reference
photocurrent that can be used for measurement at the receiver. Time gating allows
detecting the amplitude and phase of the terahertz pulse and provides information
about the absorption coefficient and, provided the thickness of the sample is known,
its refractive index (Taday & Newnham 2004).
Terahertz radiation (3 - 333cm-1 or 100 GHz - 0 THz) is a part of the far-infrared
region, which is located between the infrared and the microwaves region of the
electromagnetic spectrum. One of the major advantages of the low energy terahertz
radiation is the reduced probability of sample degradation. Hydrogen bond vibrations
(Jakobsen et al. 1968) and low energy lattice vibrations, so called crystalline phonon
vibrations (Taday & Newnham 2004), absorb in the terahertz region. These are
important vibrations of solid materials because they are directly affected by changes
in crystal structure, such as polymorphic transformations. Comparable to XRPD there
is little information obtained from amorphous materials in the terahertz region. The
lack of the long-range order prevents propagation of the vibration and the energy
expands diffusely within the material or scatters (Zeitler et al. 2007b). Since most of
the pharmaceutical excipients that serve as tablet or capsule fillers are amorphous or
partly amorphous, they are often transparent or semitransparent to terahertz
radiation. Thus, they cause no or little interference when investigating crystalline
drugs. Recently, amorphous material was characterised using TPS while heating the
sample. Structural relaxation and increase in molecular mobility for the amorphous
sample were visible in the absorbance spectra when transforming to the glassy or
rubbery state (Zeitler et al. 2007c).
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In addition to the intermolecular vibrations, the terahertz spectral information may
contain low frequency intramolecular vibration making it complicated to assign bands
(Taday 2004). Nevertheless, initial attempts to reveal the origin of the bands in the
phonon spectra of carbamazepine have shown promising results (Day et al. 2006).
The authors compared spectra calculated from harmonic rigid molecule dynamics
calculations on the polymorphic structures using boundary conditions to the spectra
of the polymorphic forms, taken at low temperature. Promising results in assigning
bands were also achieved by comparing solid-state density functional theory
calculations to the terahertz spectra of an explosive (Allis & Korter 2006).
TPS has been successfully used to determine polymorphic forms of various APIs.
Kogermann et al. (2007) have shown that dehydration of piroxicam was detectable in
compacts. Strachan et al. (2004) have investigated polymorphic forms of
carbamazepine, enalapril maleate, indomethacin, and fenoprofen calcium. In a
subsequent study by the same authors (Strachan et al. 2005) TPS was used to
quantify the degree of crystallinity and polymorphism in binary mixtures in
conjunction with partial least squares (PLS) regression. Furthermore, the content of
acetaminophen in tablets was measured in transmission mode and results were
compared to the destructive standard method, high performance liquid
chromatography (HPLC) (Spencer et al. 2007). In order to characterise powders,
formulated products, and liquids, terahertz spectra can also be obtained with an
attenuated total reflection (ATR) module requiring minimal or no sample preparation
(Gradinarsky et al. 2006, Newnham & Taday 2008).
Another application in the pharmaceutical field is the imaging of solid dosage
forms, e.g. coated tablets, and soft and hard gelatine capsules (Fitzgerald et al.
2005, Zeitler et al. 2007a). A change in the physico-chemical properties at a sample
interface is visible in the terahertz time domain waveform. This is due to a change in
the refractive index (RI) and absorption coefficient in the sample material. TPI derives
coating quality related information from the surface and interface reflection of the
sample. The technique has been employed to determine the coating thickness of
single and multiple layer-tablets, coating uniformity, and coating integrity in a non-
destructive manner using the time domain information and the terahertz electric field
peak strength (TEFPS) (Zeitler et al. 2007a, b, Ho et al. 2008). The TEFPS can be
calculated from the signal reflected off the coating surface normalised by the
magnitude of the incident pulse: though it is sensitive to scattering effects, it can be
used to gain information on the density of the coating. Using the information of the
scattering effects the TEFPS can be used to detect surface roughness. Furthermore,
it was possible to relate the differences in TEFPS to the dissolution behaviour of
sustained-release coated tablets and to changes in the process parameters during
the coating operation (Ho et al. 2008). Depending on the system that is analysed and
the frequency that is used, the penetration depths lies between 1 and 3 mm (Zeitler
et al. 2007a) with a depth resolution of 40 µm, a spectral resolution of 1 cm-1, and a
spatial resolution of 50 µm. A detailed description of the TPI device can be found in
the work of Zeitler et al. (2007a, b). Comprehensive reviews about analysis of solid
dosage forms with terahertz spectroscopy in general have also been recently
published (Strachan et al. 2006, Zeitler et al. 2007b).
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2.3.3. Raman spectroscopy
When a molecule absorbs energy, in this case monochromatic light from a laser
source, it may enter a higher virtual energy state. The molecule can then relax back
to the ground electronic state by emitting the same amount of energy that was taken
up resulting in elastic scattering (Rayleigh scattering). In addition, a small part returns
to a different energy level than the incident one, so called inelastic scattering.
Depending on the incident energy state of the molecule this inelastic scattering can
lead to a higher energy state of the molecule (Stokes shift) or to a lower energy state
(anti-Stokes shift). Usually in Raman spectroscopy Stokes shifts are reported
because they have a greater intensity. The disadvantage of detecting Stokes
scattering is that, depending on the structure of the molecule, fluorescence can
obscure the Stokes signals. Anti-Stokes shifts do not suffer from this interference; but
require molecules to be in a vibrational excited state; a situation that is negligible at
room temperature.
As Raman spectroscopy is readily applicable in-line and offers the possibility for
obtaining real-time data, it has been frequently used to gain insight into
pharmaceutical unit operations on a molecular level (Rantanen 2007). Water is a
poor Raman scatterer, thus Raman spectroscopy is an ideal method for monitoring
processes in which water signals may overwhelm spectra obtained with other
spectroscopic methods. It can be used to detect hydrate formation (Airaksinen et al.
2003, Jørgensen et al. 2002, Wikström et al. 2005), determining the conversion
kinetics between polymorphic forms in aqueous environment (Tian et al. 2006),
assessing the interaction of water with polymers (Taylor et al. 2001), and detecting
solid-state changes during fluid-bed drying (Aaltonen et al. 2007b, Hausman et al.
2005). Recently, trace crystallinity of amorphous APIs has been investigated after
milling (Heinz et al. 2008) and after compression of a model tablet formulation to a
compact (Okumura & Otsuka 2005). The application of Raman spectroscopy has
expanded to characterising PITs of an API in final tablets (Taylor & Langkilde 2000)
and quantifying API content in tablets (Johansson et al. 2005). Bulk solid dosage
forms have been examined in transmission mode (Matousek & Parker 2006,
Johansson et al. 2007), which was found to be more suitable for quantitative analysis
than reflection mode due to the larger sampling volume. The coating variability was
also investigated with Raman spectroscopy (Romero-Torres et al. 2005) as well as
coating thickness (Romero-Torres et al. 2006, Kauffman et al. 2006). Raman
spectroscopy was found to be an effective method for detecting counterfeit
pharmaceutical products (Fernandez et al. 2008).
2.4. Data analysis
With the increasing amount of spectral data obtained by in-line monitoring of entire
processes with vibrational spectroscopy chemometrics have become an important
tool for PAT applications in pharmaceutics. The FDA has included chemometrics,
being “multivariate tools for design, data acquisition and analysis”, as one of the PAT
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tools in their PAT initiative (FDA 2004a). Chemometrics have been successfully
applied in combination with vibrational spectroscopy in, for example, polymer
chemistry (Lachenal 1994) or agricultural and food science (Foley et al. 1998).
Lavine and Workman (2006) have recently published a review in which they
defined chemometrics being a “data microscope”. The use of multivariate data
analysis may enable detection of a cause-and-effect relationship between variables,
thus relating the association of variables with physical, chemical or biological
phenomena. It may also mislead the analyser and therefore should be applied
carefully. Data pre-treatment is a science in itself and the quality of the achieved
model depends greatly on the methods used to initially remove unwanted data
variation. To avoid pitfalls it is important to understand the source of the variation
within the data set (Doherty & Lange 2006), which can also be a result of an
instrumental problem or external interference. Another key ingredient to achieve a
reliable model is to use a representative test and training set (Brereton 2005). The
use of multivariate data analysis includes explorative data analysis, multivariate
regression and pattern recognition (classification).
2.4.1. Data pre-treatment
The methods of data pre-treatment can be divided into two groups. The first are row-
wise methods, which remove unwanted variance from each sample spectrum at a
time and should be applied first. The second group are the column-wise methods,
which act on the variables of the data and include all variance for their calculation.
Mean centering (MC), for example, is a column-wise method and centres the data
relative to the mean of the data set. This emphasises the differences in the spectral
features of the dataset. The simplest pre-treatment of the data is to select a certain
wavelength range that contains mainly noise and/or unimportant information and
exclude this range from the data set.
2.4.1.1. Savitzky-Golay smoothing and derivatives
Savitzky-Golay smoothing on its own is a powerful method to remove spectral noise.
For optimising the smoothing process it is possible to select the filter width and the
polynomial order (Savitzky & Golay 1964). Since the selection is dependent on the
application e.g. for Raman spectra containing sharper peaks than NIR spectra, a
smaller filter width should be selected.
Derivatives in combination with Savitzky-Golay smoothing remove baseline
offsets and additionally scale the data depending on their frequency. This means for
a first derivative operation the low frequency signals decrease in their signal strength
while the higher frequency signals gain more importance. This also holds true for the
second derivative. But it should also be mentioned that noise is a high frequency
signal and will be emphasised as well. The signal-to-noise (S/N) ratio therefore
decreases, as a result of the increase in noise and the decrease in actual signal
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compared to the initial absorbance. For detailed information about the behaviour of
derivatives and computational limitations in estimating true derivatives of real data
the reader is referred to the work of Mark & Workman (2003a, 2003b, 2003c, and
2004). The authors conclude that calculating derivatives may easily result in a
decreased S/N ratio. Therefore, it is important to choose the setting for the
convolution function carefully and on a case-by-case basis. When performing the
smoothing operation, it is important to determine the best parameters for convolution,
optimum spacing, and polynomial. Combined with the “right”-order derivative this
may result in an improved S/N ratio.
2.4.1.2. Standard normal variate correction
Standard normal variate (SNV) correction normalises the data. Scaling and offset
effects, so called multiplicative effects, are removed by this operation. SNV correction
centres each spectrum around zero intensity by subtracting the average of all the
spectral responses in the vector from each of the original values. In addition, each
spectrum is divided by its standard variation (Barnes et al. 1989).
2.4.2. Principal component analysis
Principal component analysis (PCA) is used to compress the data set by explaining
variance using principal components (PCs). It describes major trends within a dataset
by capturing the maximum variance.
X is the matrix of independent variables (eg. spectral intensities) and contains N
samples (columns) and M variables (rows). X will be decomposed into the scores
matrix T (an N-by-A matrix), with the number of PCs being A, the loadings matrix
being P (an M-by-A matrix), and the matrix E (N-by-M) containing the residuals.
(3) ETPX += '
The first PC describes the greatest amount of variance in the data set. It passes
through the origin and describes the maximum variance of the data. The second PC
is orthogonal (independent) to the first PC and describes the second most variance.
With every subsequent PC the variance decreases. Consequently, after a certain
amount of variance explained the subsequent PCs will only contain noise. It is
therefore important to select the optimal number of PCs to include only meaningful
data in the model. There are several methods to detect the optimal number of PCs.
One is to plot the number of PCs against the eigenvalues, which result from the
decomposition of the original matrix. If the ratio of the eigenvalues for the two
successive PCs drops drastically, starting from the first PC, the following PCs should
not be included in the model.
In order to interpret the PCA model, the lack of fit Q (squared process error) helps
to describe the influence of a sample on the model and can be used to detect
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outliers. The Hotelling T2 describes the leverage of a variable or the variation in each
sample within the model. It can be presented as a geometrical distance to the mean
of the data and thus outliers can be detected visually.
PCA is a popular data analysis method in pharmaceutical research. It has been
used to detect hydrate formation (Jørgensen et al. 2002) and different phases during
fluid-bed granulation (Rantanen et al. 2005). Tablets compressed with either a single
punch or rotary tablet press were classified with PCA according to their tablet
hardness (Cogdill et al. 2005a).
2.4.3. Partial least squares regression
Partial least squares (PLS) regression (Wold 1966, Wold et al. 1983, Wold et al.
2001) combines features of PCA and multiple linear regression in order to create a
model between X and Y scores. It is an iterative method, which is used to develop a
linear model. This model combines fundamental relationships between the measured
variables, X, and a property of interest, Y (unlike PCA, which does not use Y in the
calculations). So the first step of a PLS regression is a decomposition step,
comparable to PCA, and the detection of components, here called latent variables
(LVs). These components should explain the covariance between X and Y. This is
followed by a regression step to achieve correlation.
As in PCA, the selection of a suitable number of latent variables is important;
otherwise the model may be overfitted or underfitted. One of the methods that is
frequently used in chemometrics applies cross-validation. During cross-validation
samples of the data set are grouped into subsets. The performance of the model
achieved using one of these subsets can be tested with unseen data (remaining
subsets) and results in the root mean squared error of cross-validation (RMSECV). In
the predicted error sum of squares (PRESS) plot the number of latent variables is
then plotted against the RMSECV. The increase after a minimum in the RMSECV
indicates overfitting. Another sign of overfitting is the presence of noise-related
features in the regression vector, which tries to combine a good fit to the observed
variables with the ability to accurately predict variables. If noise is included in the
model and correlates with X, it will be reflected in the regression vector and will lead
to poor predictions.
PLS regression of multivariate data has been employed to quantify polymorphic
and pseudo-polymorphic transformations, for example, during storage (Blanco et al.
2005), to predict the API content in compressed tablets (Cogdill et al. 2005b), and to
determine the coating thickness (Andersson et al. 2000). Chalus et al. (2007)
compared modelling the drug content in tablets using PLS regression and artificial
neuronal network. In this study the artificial neuronal network model provided greater
linearity and correlation between the reference and the predictions than the PLS
model.
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3. Aims of the study
In order to gain a better insight into pharmaceutical manufacturing processes, PAT
was applied to a variety of processes, such as blending, wetting, drying, and coating.
These processes were investigated by vibrational spectroscopy. Specific aims of this
study were:
· to obtain the optimal blending time for a double cone mixer by monitoring the
blending process at-line with NIR spectroscopy
· to investigate the solid-state changes of APIs during granulation, extrusion, and
spheronisation with Raman and NIR spectroscopy using XRPD as a reference
method,
· to study the solid-state changes of an API during drying processes by first testing
the suitability of the Raman and NIR spectroscopy at-line during an oven-bed
drying process and then applying NIR spectroscopy in-line into a fluid-bed drying
process,
· to investigate the potential of a novel small-scale coating device to obtain a
calibration model for coating thickness prediction that can be applied to a coating
drum process using NIR spectroscopy,
· to test the potential of TPI as an off-line analytical tool for coating quality
assurance.
EXPERIMENTAL
20
4. Experimental
Details about the experimental materials and methods are reported in the original
publication (I-V) and are summarised below.
4.1. Materials
4.1.1. Raw materials
The model compounds used in publication I were anhydrous theophylline (100 M, Ph
Eur, Orion Pharma, Espoo, Finland) and anhydrous nitrofurantoin (Sigma-Aldrich
Chemie, Steinheim, Germany). For preparing pellets in publication I lactose
monohydrate (80 M, Pharmatose; DMV Pharma, Veghel, The Netherlands) and
microcrystalline cellulose (50 M, Emcocel; Penwest Pharmaceuticals, Nastola,
Finland) were used.
Erythromycin dihydrate (Pharmacia&Upjohn Company, Kalamazoo, MI, US) was
used in publications II and III with microcrystalline cellulose as a filler (Avicel® PH101,
FMC, Cork, Ireland) for the pellets.
For publication IV the tablets contained high density polyethylene (PE, Inducted,
Volketwil, Switzerland, particle size <10 µm) and amorphous fumed silica (Aerosil®
200, Degussa, Essen, Germany). The coating solution consisted of a polyvinyl
acetate (PVA) suspension (Kollicoat SR30D®, BASF, Ludwigshafen, Germany) and a
polyvinyl alcohol-polyethylene glycol graft copolymer (Kollicoat IR®, BASF,
Ludwigshafen, Germany), triethylcitrate (Fluka, Buchs, Switzerland), glycerol
monostearate (BDH Chemicals Ltd., V W R International, Poole, England), and
polysorbate 80 (Tween® 80 V Pharma, Uniqema, Everberg, Belgium). The solvent
used in all studies was purified water.
The tablets compressed for publication V contained diprophylline (BASF,
Ludwigshafen, Germany), lactose monohydrate (Flowlac®, Meggle Wasserburg
GmbH, Wasserburg, Germany), and vinylpyrrolidone-vinyl acetate copolymer
(Kollidon VA 64®, BASF, Ludwigshafen, Germany). The sub-coat composition
contained Kollicoat VA 64 and polyethylene glycol (PEG) 600 and for the main coat
composition Kollicoat SR30D®, Kollicoat IR®,  talc,  FD&C  blue  dye  (BASF,
Ludwigshafen, Germany), and triethylcitrate were used.
4.1.2. Preparation of pellets (I-III)
The powders were dry-mixed in a double cone mixer. Pellets were manufactured
using continuous extrusion-spheronisation (Nica M6L mixer/granulator; Nica E140
radial screen extruder; Nica S320 spheroniser; Nica System AB, Sweden). The
blended powder mixture was wetted with purified water in a mixer/granulator.
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4.1.3. Preparation of tablets cores (IV)
The composition, containing HDPE and Aerosil® 200, was mixed with a Turbula®
mixer (Bachofen AG Maschinenfabrik, Basel, Switzerland). Flat-faced tablets and
biconvex tablets (punch diameter = 9 mm) were compressed using an instrumented
single punch tablet machine (Korsch EK0, Erweka Apparatebau, Berlin, Germany).
The tablets (m = 170 mg) were compressed to a fixed load of 50 N.
4.1.4. Preparation of coating suspension (IV)
Purified water with polysorbate 80 was heated to 70°C and mixed with glycerol
monostearate. The water soluble polymer Kollicoat IR® was dissolved in purified
water. The achieved homogeneous solution was combined with Kollicoat® SR30D
and the suspension containing polysorbate 80 and glycerol monostearate. Finally the
plasticizer triethylcitrate was added. The whole suspension was stirred for 24 hours
prior to use.
4.1.5. Preparation of sustained-release coated tablets (V)
The tablets were supplied by Bohle (L.B. BOHLE Maschinen & Verfahren GmBH,
Ennigerloh, Germany). The sub-coat solution was prepared by dissolving Kollidon VA
64® in purified water and adding PEG 600. For the preparation of the coating
suspension for the main coat Kollicoat IR® was dissolved in demineralised water and
combined with the solution containing the dissolved colourant. Afterwards, firstly
Kollicoat SR30D® and then the plasticizer, triethylcitrate, were added. The
suspension was stirred for 24 hours and finally a suspension of talc in purified water
was added.
4.2. Methods
4.2.1. Drying processes (II, III)
For publication II the pellets were dried in a conventional oven-tray dryer (Heraeus
UT6760, Heraeus, Hanau, Germany) at 30°C or 60°C. Before sampling, the whole
bed was circulated so that the sample was a representative mixture of pellets from all
areas of the bed.
A multipart microscale fluid-bed powder processor (MMFD, Ariacon Oy, Turku,
Finland) was used to dry the pellets (III) at 30°C, 45°C and 60°C. The moisture
content of the inlet air was set to be 0.4 to 2.4 g water per kg of dry air at 22°C. The
process was monitored by in-line NIR spectroscopy through the fluidisation chamber
made of glass.
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4.2.2. Coating processes (IV)
The flat-faced tablets, fitted into the moulds of the small-scale rotating plate device,
passed a spraying unit, a heating unit (Sartorius thermo control, Sartorius AG,
Goettingen, Germany), and an NIR probe during each rotation. A total of 20 tablets
for each process were labelled, weighed, and their thickness was measured
individually before and after the coating process using a digital micrometer (Sony
digital micrometer U30-F, Sony Magnescale Inc, Tokyo, Japan).
The biconvex tablets were coated using an instrumented laboratory-scale side-
vented drum coater (Thai coater, model 15, Pharmaceuticals and Medical Supply Ltd
Partnership, Bangkok, Thailand) (Ruotsalainen et al. 2002). The coating batch
comprised 1.0 kg tablet cores. Before and after coating 100 tablets were weighed
and their heights were measured to calculate the coating thickness.
4.2.3. Near-infrared spectroscopy (I-IV)
For publication I and II the NIR measurements were made with a Fourier-transform
(FT)-NIR spectrometer (Bomem MD-160 DX) using Bomem-GRAMS software
(version 4.04; Galactic Industries Inc, Salem, NH, US) and Teflon as a reference
(99% reflective Spectralon; Labsphere Inc, North Sutton, NH, US).
For papers III and IV the measurements were performed with a diffuse reflectance
NIR spectrometer (NIR-256L-2.2T2, Control Development Inc., South Bend, IN, US)
using a thermoelectrically cooled 256 array detector, a tungsten light source, and a
fibre-optic reflectance probe, with Teflon serving as reference.
4.2.4. Raman spectroscopy (I)
The Raman spectra were measured at-line using a CCD Raman spectrometer (CDI
Raman 785-1024; Control Development, Inc, South Bend, IN, US) with a 785-nm NIR
diode laser (Starbright, Torsana Laser Technologies A/S, Skodberg, Denmark).
4.2.5. X-ray powder diffractometry (I-III)
X-ray powder diffraction (XRPD) was performed using a theta-theta diffractometer
(D8 Advance, Bruker axs GmbH, Karlsruhe, Germany) operating in symmetrical
reflection mode with CuK? radiation (1.54 Å) and Göbel Mirror bent gradient
multilayer optics. The scattered intensities were measured using a scintillation
counter. Measurements were performed from 5 to 40º (2 theta) with steps of 0.05º (I)
and 0.1º (II, III) and a measuring time of 1 s/step using a voltage of 40 kV and a
current of 40 mA. Wet pellet samples of studies (II, III) were also measured with
variable temperature XRPD.
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4.2.6. Terahertz pulsed spectroscopy and imaging (V)
For studying the refractive index of the materials in the different coating solutions a
TPS 1000TM (TeraView Ltd, Cambridge, UK) was used. Each material was
compressed with polyethylene into pellets. Samples were measured in transmission
rapid-scanning mode and referenced against the spectrum of a pure polyethylene
pellet for solids in dry nitrogen atmosphere.
The TPITM imaga 2000 system (TeraView Ltd, Cambridge, UK) was used to
achieve 3D imaging of the sustained-release coated tablets. The data acquisition
process consisted of two steps. A surface model was created at the laser gauge that
formed the basis of the subsequent terahertz scan for construction of a 3D terahertz
image. Terahertz mapping was performed in point-to-point scan mode with a step
size of 200 µm. The axial resolution in the z-direction was about 38 µm. The data
were analysed using the TPIviewTVL imaging software (version 2.3.0).
4.2.7. Moisture content analysis (I-III)
The moisture content of the pellets was analysed with a moisture content analyser
(Sartorius moisture analyser MA 100 Sartorius GmbH, Göttingen, Germany).
4.2.8. Multivariate data analysis (I, III, IV)
For publication I the second derivative was calculated with MATLAB software
(MATLAB 6.5; MathWorks Inc, Natick, Massachusetts, USA) using an 11-point,
second order polynomial Savitzky-Golay smoothing operation. In publication III the
data was pre-treated calculating a Savitzky-Golay first derivative with a filter width of
11-points and a second order polynomial fit. Furthermore, the data was SNV
corrected and mean-centred. The data obtained for the coating processes (IV) was
smoothed using a 21-point, second order polynomial Savitzky-Golay algorithm, then
SNV corrected, and finally mean-centred.
The principal component analysis (PCA) for publication I was performed with
SIMCA-P (SIMCA-P 8.0, Umetrics AB, Umeå, Sweden). The PCA analysis for
publication III was performed with PLS-toolbox (PLS-toolbox 4.0.1, Eigenvector
Research, Inc., Wenatchee, WA, US), as was the PLS regression model for
publication IV.
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5. Results and discussion
5.1. Solid-state properties
Theophylline (TP) belongs to the xanthine family of compounds. The therapy of
respiratory diseases like asthma or chronic obstructive pulmonary disease (COPD) is
its main therapeutic application. TP exists in two enantiotropic polymorphic forms: the
anhydrate form I, which is stable at high temperatures, and the anhydrate form II,
which is the stable form at room temperature (Burger & Ramberger 1979). Under
conditions of high humidity or in aqueous environment the anhydrate forms readily
convert to the monohydrate (Herman et al. 1988). Furthermore, there has been a
metastable anhydrate identified (Phadnis & Suryanarayanan 1997).
Nitrofurantoin (NF) is an antibiotic used to treat urinary tract infections. There
have been four polymorphic forms identified so far: NF monohydrate I and II and ?
and ? anhydrate (Pienaar et al. 1993a, b). The ? form of NF anhydrate has been
used as the starting material in publication I and was readily identified by the NIR
spectrum measured (Figure 3a, I). It showed characteristic peaks at 1551, 1631,
1701, 1745 and 1987 nm (Aaltonen et al. 2007b). NF monohydrate form II has been
used as a reference was and has been found to be the more stable form (Otsuka &
Matsuda 1994).
Erythromycin is a macrolide antibiotic. One of the different polymorphic forms of
erythromycin (EM) is the channel hydrate EM dihydrate that tends to dehydrate upon
drying. EM dehydrate is isomorphic to EM dihydrate (Stephenson et al. 1997,
Miroshnyk et al. 2006) but highly hygroscopic (Stephenson et al. 1998), and thus
prone to cause problems during processing (Bauer et al. 1999). The role of water as
the solvent of crystallisation was found to be unique because desolvation of EM
crystallised from other solvents (acetate, ethanol, isopropanol and
methylethylketone) resulted in a collapse of the crystal lattice and formation of
amorphous material (Mirza et al. 2003). EM can also exist as an amorphous form
and an anhydrate. EM anhydrate recrystallises from the dehydrate melt at about
150°C (Stephenson et al. 1997, Miroshnyk et al. 2006). In this study EM anhydrate
has not been considered for PITs due its high activation energy (Wang et al. 2006).
A scheme is presented in Table 3 summarising which techniques were used to
gather information about a specific system during the unit operations.
5.2. Blending (I)
The blending of a three component formulation containing NF, microcrystalline
cellulose (MCC), and lactose monohydrate was monitored by NIR spectroscopy. The
data obtained during blending was analysed with PCA (first two PCs of the second
derivative, Savitzky-Golay smoothed data). It was found that after 5 min the
formulation was sufficiently mixed. After 10 min, there were no changes in
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homogeneity detectable. Thus, NIR spectroscopy in combination with PCA was
found to be a suitable process analytical tool to determine the optimal blending time.
Table 3. Scheme of the processes monitored during the present work
System In-
line
At/
off-
line
Technique
used
Pharmaceutical unit
operations
Information obtained
NF, TP,
EM
X
XRPD, NIR
and Raman
spectroscopy
Identifying raw material, obtaining
reference data for all known
polymorphic forms
NF X
NIR
spectroscopy
Blend uniformity, end-point
detection
NF, TP,
EM
X
XRPD, NIR
and Raman
spectroscopy
Hydrate formation for NF and TP,
moisture content determination
NF, TP,
EM X
X XRPD, Raman
and NIR
spectroscopy
Moisture content determination,
following dehydration for NF, TP
and EM, end-point detection
HDPE X
NIR and
Raman
spectroscopy
No changes after exposure to
high pressure detectable
HDPE,
coating
solution
X
X
NIR
spectroscopy,
TPS and TPI
Monitoring coating thickness
development, characterisation of
coating variations and uniformity
5.3. Extrusion-Spheronisation (I, II)
The manufacturing steps of pelletisation (granulation, extrusion and spheronisation)
were analysed at-line using NIR spectroscopy, Raman spectroscopy, and XRPD.
Due to the high water saturation of the samples, there was no chemical information
that could be obtained by the NIR spectral data in any of the used formulations (I, II)
containing either TP, NF (I), or EM (II). Nevertheless, the baseline shift indicated the
increase of particle size after granulation, extrusion, and spheronisation (Figures 2
and 3, I).
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With Raman spectroscopy it was possible to detect solid-state transformations of
anhydrous TP and anhydrous NF upon wetting (I). The characteristic peaks between
the anhydrous and the monohydrate form of TP were difficult to detect due to the low
drug content (10% w/w) and were often obscured by excipient bands. Subtle
changes in the area of 1700 to 1650cm-1, however, indicated the formation of the
monohydrate (Figure 5a, I). This finding was supported by the reflection pattern of
the XRPD analysis, showing characteristic reflections at 11.4° (2?) and 14.7° (2?) for
TP monohydrate after granulation (Figure 4b, I). Hydrate formation of anhydrous TP
to the monohydrate form has been frequently reported (Jørgensen et al. 2002,
Otsuka et al. 1990, Räsänen et al. 2001). Amado et al. (2007) have investigated
hydrate formation of anhydrous TP, being a one step random nucleation process,
with Raman spectroscopy and determined the critical relative humidity to be >79% at
room temperature (Otsuka et al. 1990).
The formation of NF monohydrate was readily detectable by Raman spectroscopy
(Figure 5 a and d, I) and confirmed by the change of XRPD reflections (Figure 4c, I).
While the dry powder showed characteristic reflections for NF anhydrate at 14.4° (2?)
and 28.8° (2?), the sample taken after granulation showed reflections at 13.9° (2?)
and 27.2° (2?), which are characteristic for the monohydrate.
In the formulation containing EM dihydrate (II) it was not possible to detect any
solid-state changes with Raman spectroscopy, even though the drug content was
relatively high, at 50% w/w. Fluorescence, caused by the excipent MCC, obscured
significant Raman bands. This made it impossible to differentiate between EM
dihydrate, dehydrate, and amorphous EM. The XRPD reflection pattern, however, did
not indicate any solid-state transformation during pelletisation (Figure 3, II).
Considering that the formulation with EM contained a dihydrate and the forms that
may occur required a dehydration process (dehydrate, anhydrate), or the loss of the
long range order (amorphous EM) there were no solid-state changes expected during
pelletisation.
5.4. Drying (I, II, III)
The effect of the drying temperature (60°C, 100°C and 135°C) for the pellets
containing TP and NF (I) was investigated using an infrared drier. The Raman
spectra and XRPD pattern of TP pellets dried at 60°C still contained characteristics of
the monohydrate while the pellets dried at higher temperatures indicated dehydration
to TP anhydrate (Figure 4b, I and Figure 5b, I). TP monohydrate is a channel hydrate
and loses its water molecules readily at around 80°C (Aaltonen et al. 2007b). It forms
the anhydrate via a metastable anhydrate form (Phadnis & Suryanarayanan 1997,
Aaltonen et al. 2007b) with the dehydration process being reversible. Amado et al
(2007) have detected structural similarities between TP monohydrate and the
metastable anhydrate, which apparently retains the intermolecular interactions of the
monohydrate. After this cooperative release of water molecules structural
rearrangement is evident. This process is readily reversible and the average
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crystallite size of theophylline monohydrate is higher than that of the anhydrate form
(Airaksinen et al. 2004). Thus, it seems likely that the dehydration process of TP
monohydrate follows the class II cooperative-reorganisation mechanism.
For the NF pellets the dehydration occurred only at the highest temperature of
135°C (Figure 4c, I and Figure 5c, I), but it was not possible to detect into which
anhydrate NF transformed. Variable temperature XRPD analysis of NF monohydrate
(Karjalainen et al. 2005, Kishi et al. 2002) detected formation of NF anhydrate at
around 140°C via formation of amorphous material. In a high humidity atmosphere
Kishi et al. (2002) were not able to detect any amorphous halo background when
performing variable temperature XRPD. This indicates that at high humidity
dehydration of NF monohydrate follows the Class I cooperative-crystallisation
mechanism while at low humidity the Class I destructive-crystallisation mechanism is
followed. The dehydration of NF monohydrate form II has been studied (Jørgensen et
al. 2006) using differential scanning calorimetry with the onset of dehydration
detected at 115°C. It gradually crystallises at temperatures between 132 and 137°C.
It is evident that TP loses its water molecules more readily than NF. This can be
explained by the hydrate structure: NF is an isolated site hydrate while TP is a
channel hydrate.
Figure 3. Unit cell of EM dihydrate with the water molecules highlighted.
For the study containing EM dihydrate (Figure 3) the crucial process step was the
drying step. NIR and Raman spectroscopy were first tested at-line in an oven-bed
drying process (30°C and 60°C). Solid-state changes were confirmed by XRPD. The
oven-bed drying process had the advantage of providing easy access to the
samples. The data obtained by NIR spectroscopy showed the occurrence of
isomorphic EM dehydrate for one batch dried at 60°C (Figure 6c, II). Even though EM
dihydrate and its dehydrated form have the same crystal structure, there are minor
differences in the reflections of the XRPD pattern detectable. These distinct
reflections occur at 9.9° (2?), 10.3° (2?) and 13.1° (2?) for EM dihydrate and at 9.7°
(2?), 10.2° (2?) and 13.3° (2?), respectively, for EM dehydrate. The crystal lattice
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merely relaxes when the water evaporates, causing these shifts in XRPD.
Dehydration consequently follows the Class II topotactic mechanism (Miroshnyk et al.
2006).
The wet pellets (obtained after spheronisation) were additionally examined with
variable temperature XRPD (Figure 7, II). At a temperature of about 70°C the
reflection pattern was equivalent to that of EM dehydrate.
Figure 4. Scores plot of the first principal components of pellets containing EM and MCC
fluid-bed dried at 45°C (second batch). Principal component analysis of NIR spectra (first
derivative, Savitzky-Golay smoothed, standard normal variate, mean centred).
After ensuring that NIR spectroscopy is sensitive to the transformation of EM
dihydrate into the isomorphic EM dehydrate, a diffuse reflectance NIR probe was
used to monitor the fluid-bed drying process in-line. As presented in publication III, it
was possible to detect dehydration of EM dihydrate for both batches dried at 60°C
(Figure 5b, III) and for one batch dried at 45°C (Figure 4). For this purpose the
wavelength range of 1360 to 2000 nm was selected. Further data pre-treatment
included a Savitzky-Golay first derivative smoothing operation and normalisation
using SNV correction. Finally the data was mean centred and PCA was performed.
Only the first two PCs were used for this analysis combining between 86 to 95% of
the variance. The first and the second PC were able to detect the structural
differences between EM dehydrate and EM dihydrate. The third PC (about 2%) was
mainly able to show that EM dihydrate, EM dehydrate, and amorphous EM exhibited
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greater differences to the spectra of the pellets than the blends of EM dihydrate/MCC
and EM dehydrate/MCC.
For the first part of the process the decreasing signal of the first overtone OH-
stretching (Figure 5) marks the evaporation of the free and unbound water (first
arrow). The second part of the process is dominated by the blueshift of the
combination band of water from 1937 nm for EM dihydrate/MCC to 1926 nm for EM
dehydrate/MCC (third arrow). This is a result of evaporation of the lattice bound water
(Figure 4, III). These changes, as well as the appearance of the peaks between 1680
to 1730 nm (second arrow), are important wavelengths in the loadings plot of the first
and second PCs (Figure 5c, III).
Figure 5. Standard normal variate corrected near-infrared spectra of the fluid-bed drying
process of the EM pellets dried at 60 °C (second batch).
Though the first trace of EM dehydrate could not be detected using PCA analysis,
the physical change in the evaporation process from free to chemically bound water
is indicated by the change in slope in the PCA scores plot. Therefore, it enables
suitable end-point detection of the drying process before the occurrence of EM
dehydrate is evident.
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5.5. Film coating process (IV)
Tablets containing high density polyethylene and Aerosil® 200 were coated using the
rotating plate system. A detailed description of this set-up can be found in publication
IV. These tablets, individually labelled, were coated with 5 to 25 plate rotations,
resulting in different coating thicknesses of 25 to 400 µm. Each process was
monitored by in-line NIR spectroscopy. Final spectra of each of the coated and dried
tablets (n = 20) were taken and assigned to the corresponding coating thickness. The
tablet thickness was measured before and after the coating process individually with
a digital micrometer.
After selecting the wavelength range of 1160 to 1780 nm, the data was pre-
processed using a smoothing operation (Savitzky-Golay), SNV correction, and MC.
The data was divided into the calibration set and the test set. The calibration set was
used to calculate the PLS regression model.
Figure 6. PRESS-plot (a), regression vector of the partial least squares model, and the
mean spectra of the calibration set (b).
Three LVs were selected for the PLS regression model. The PRESS plot (Figure
6a) clearly indicated that three LVs were sufficient for the model. The regression
vector (Figure 6b), that can be used to indicate model over-fitting by random
variation, showed hardly any inclusion of noise when choosing three LVs. As
presented in publication IV, the first LV (Figure 7a) represents the baseline changes
attributable to an increase of particle size of the tablets and also a change in surface
texture due to the coating.
In addition, the signal from the tablet core decreased with increased coating
thickness according to the Beer Lambert law, and thus contributing to the changes in
the baseline. The first LV has the greatest power to separate the data points
according to their thickness. For the coating thickness prediction, however, the
second LV, describing the chemical signal of the coating solution, and the third LV,
showing the signal of the tablet core, are crucial.
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Figure 7. The signals contributing to the LVs in the weights plot (a). Coating thickness
prediction of the calibration and test set (b). Standard normal variate corrected spectra of the
in-line near-infrared data obtain during the coating drum process (c). The standard normal
variate corrected spectra from the rotating plate coating process (d). Coating thickness
prediction (e) of in-line near-infrared data from the coating drum.
The results of the cross validation showed a suitable prediction capacity when
applied to the test set (RMSEC: 28.2 µm, RMSECV: 29.0 µm, RMSEP: 28.5 µm).
When examining the influence plot (Figure 6b, IV), the samples with a coating
thickness higher than 300 µm showed a generally negative Y-studentised residual,
meaning the model predicted a lower coating thickness than measured. This showed
the flaws of the model for predicting thicker coatings due to the limitations of the Beer
Lambert law.
After calibrating and testing the PLS model (Figure 7b), the model was applied to
data obtained by in-line NIR spectroscopy during a coating drum process. For this
coating process the same tablet composition was used as for the rotating plate
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system only the shape of the tablet cores differed. For the rotating plate system flat-
faced tablets were more suitable because they allowed equal distribution of the
coating solution. In contrast to this, biconvex tablets were required for the coating
drum process to prevent the tablets from sticking together. The SNV corrected
spectra of both processes (Figure 7c and e) contained many similarities, although
there was more noise visible in the spectra obtained from the coating drum process.
The coating thickness prediction (Figure 7d) of the coating drum process resulted
in a thickness of 240 µm while the digital micrometer measured 210 µm. The
difference between the prediction of the PLS model and the measured coating layer
thickness can be explained by the error of the digital micrometer (approximately
10%). For both measurements (before and after coating) this resulted in an error of
about 30 µm thus the difference of 30 µm was within the error-limits. Coating quality
differences were mainly due to the ineffective drying unit attached to the rotating
plate and the wave-like pumping of the peristaltic pump used and may have added
up to the error of the digital micrometer.
5.6. Analysis of the quality of coating (V)
At first, before the actual measurements of the coated tablets were performed, the
refractive index (RI) of the coating system was determined. This was necessary for
an accurate coating thickness calculation, but avoided the need for a calibration
model to be developed. The coating thickness is calculated from the time delay
between the surface reflection and the reflection from the interface of the coating and
the tablet core; taking into account the speed of light and the refractive index (n) of
the examined system. Thus, the RI of each solid component used in the coating
solution was determined using TPS. The RI of the coating was estimated based on
the weight percentage of each component in the coating. The calculated value of
1.85 roughly agreed with the RI value of 1.87 obtained from the coating on the tablet.
The coating thickness calculations were based on the measured value of 1.87. Even
without the determination of an accurate RI, it is still possible to extract information
that enables one to compare batch-to-batch variability.
For the tablet coating quality analysis ten coated tablets were measured by TPI.
The whole tablet was scanned at the laser gauge to create a surface model of both
tablet sides and the central band. Based on this morphological model the 3D
terahertz image was created by first scanning tablet side a, then the central band and
finally tablet side b. The 3D terahertz image was constructed from terahertz
waveforms, which contained all the information required to form the basis of a voxel
of the tablet (Figure 1, V). The reflection from a tablet interface resulted in either a
maximum (if the RI of the subsequent system was greater) or a minimum (if the RI of
the subsequent system was smaller). These interfaces in this study were between:
air/main coat (maximum: nair <  nmain coat), main coat/sub-coat (minimum: nmain coat >
nsub-coat) and sub-coat/tablet core (minimum nsub-coat >  ncore). Since the interface
between the two coating layers and between sub-coat and tablet core both resulted
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in a minimum and the thickness of the coat was under the diffraction limit of the TPI,
it was not possible to resolve the two minima. The results show a broadened peak in
the time domain wave form. Consequently, the thickness of the sub-coat could not be
determined by TPI in this particular study.
Figure 8. False coloured image (a) of tablet side b reveals the coating thickness
distribution. The histogram (b) shows the bimodal coating thickness on the tablet side. The
unit scale is given in µm. The photograph taken of this tablet side is shown in (c).
The average layer thickness of both tablet sides (sample 3) was 149 µm (Table 1,
V) and comparable with the reference method – an optical microscope (a destructive
method), which also resulted in an average thickness of 149 µm. The TPI 2D images
on one tablet surface showed variability in the coating thickness. Tablet side b
(Figure 8a) revealed a thickness varying between 148 µm at the edges and a
minimum of 130 µm on the centre of the side b. The histogram of the layer thickness
distribution (Figure 8b) showed bimodal thickness distribution (of about 136 µm and
152 µm) around the mean of 142 µm.
When observing the 3D image of the tablet side a and the central band (Figure
9a) two main conclusions can be drawn. Firstly, side a is obviously more evenly
coated and has a thicker coating than tablet side b (average thickness side a: 152
µm). Secondly, the coating thickness of the central band is lower than the coating
thickness of the tablet sides. The mean coating layer thickness of the central band of
all ten tablets was found to be 33 % lower than the thickness of the tablet sides.
To compare the results for the measurements between the TPI and the optical
microscope, a student’s t-test was performed and showed good agreement between
the two techniques (TPI and optical microscopy) on the measurements of coating
layer thickness for the tablet sides (with a p value of 0.17). The tablet central band,
on the other hand, showed a p value of 0.01 indicating greater variation between the
two analytical methods due to greater terahertz signal scattering. This is a result of
higher morphological curvature around the tablet central band.
Nevertheless, TPI has several advantages over optical microscopy. The greatest
advantages are that it is a non-destructive method and able to give an image of the
whole tablet. In addition, it provides fast detection of the coating distribution and the
coating uniformity, which helps to reveal defects in the coating that are not visible to
the naked eye (Figure 8c).
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Figure 9. 3D image (a) of the tablet side a and the central band. The colour bar scale is in
µm, the x, y and z axis give the dimensions of the tablet in mm. The peak intensity image (b)
of tablet side b reconstructs the orange peel defects of the coating. The virtual cross section
through the tablet (c) reveals the different interfaces.
Another advantage is in the analysis of defects. The blister defect on tablet side a,
which is visible in Figure 8a and c, was located by virtually slicing the image in the z-
axis (Figure 7, V). The depth of the blister was determined to be 314 µm, exceeding
the coating layer, and is obviously a tablet defect. By slicing the image in the x
direction (Figure 5, V) the defect was localised and the diameter was determined to
be 0.7 mm.
It was also possible to measure the surface roughness of the coating (orange peel
defect) by determining the TEFPS. The red areas in the peak intensity map (Figure
9b) exhibit domains of smooth coating when the majority of the light emitted was
reflected back or absorbed. If the pulse hits rougher areas of the coating a greater
amount of the pulse will be scattered, leading to a decrease of the detected signal.
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This is marked by the blue-green areas in Figure 9b. When examining the surface
roughness, the RI was found to be proportional to the reflectivity and varied over the
surface of the coated tablet. Due to the different methods in measuring the coating
thickness and the surface roughness, the coating thickness determination was not
affected by the intensity changes due to the surface roughness.
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6. Summary and conclusions
Vibrational spectroscopy has been used to gain insight into process-induced
transformations. Monitoring the blending of a three component system by near-
infrared (NIR) spectroscopy provided information about the blend homogeneity, thus
making it possible to determine the end point of the blending process. Hydrate
formation was observed by Raman spectroscopy for nitrofurantoin and theophylline
during pelletisation. NIR spectroscopy was not able to detect any changes during this
processing step due to the strong signal of the water used as granulation liquid. For
erythromycin dihydrate it was not possible to detect any solid-state changes by either
technique. Dehydration was detected at-line with XRPD and Raman spectroscopy for
nitrofurantoin and theophylline. Being sensitive to hydrogen bonding changes NIR
spectroscopy was successfully used to follow the dehydration for all three drugs
under investigation. It was even possible to detect the formation of an isomorphic
dehydrate of erythromycin during a fluid-bed drying process using in-line NIR
spectroscopy in combination with principal component analysis.
To study coatings, NIR spectroscopy was used to monitor a small-scale rotating
plate coating process, and a calibration model was developed using partial least
squares regression. This model was then used to predict the coating thickness of
tablets of the same core composition, coated with the same coating solution, but
coated in a regular coating pan. The prediction was just within the error limits but
reducing the errors will result in better data, and thus enable a better prediction.
Terahertz pulsed imaging, used to examine sustained-release coated tablets, was
able to assess the coating layer thickness, distribution, reproducibility, and uniformity.
Due to the possibility of producing 3D images of the measured tablet, the technique
can be used to localise and quantify coating defects.
It can, therefore, be concluded that vibrational spectroscopy based tools were
suitable for monitoring different production steps at-line as well as in-line. The
increase in process understanding may enable modelling physico-chemical
phenomena that occur under specific conditions. This will greatly improve the quality
of pharmaceutical products and, in the long run, may have a contribution to the
development of novel techniques for pharmaceutical production and new
applications.
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